Page last updated: 2024-10-27

fenofibrate and Osteonecrosis

fenofibrate has been researched along with Osteonecrosis in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Osteonecrosis: Death of a bone or part of a bone, either atraumatic or posttraumatic.

Research Excerpts

ExcerptRelevanceReference
"Recent clinical trials in children with acute lymphoblastic leukemia (ALL) indicate that severe hypertriglyceridemia (> 1000 mg/dL) during therapy is associated with increased frequency of symptomatic osteonecrosis."5.62Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice. ( Cai, X; Finch, ER; Janke, LJ; Jenkins, DA; Karol, SE; Li, L; Payton, MA; Relling, MV, 2021)
"Recent clinical trials in children with acute lymphoblastic leukemia (ALL) indicate that severe hypertriglyceridemia (> 1000 mg/dL) during therapy is associated with increased frequency of symptomatic osteonecrosis."1.62Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice. ( Cai, X; Finch, ER; Janke, LJ; Jenkins, DA; Karol, SE; Li, L; Payton, MA; Relling, MV, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Finch, ER1
Payton, MA1
Jenkins, DA1
Cai, X1
Li, L1
Karol, SE1
Relling, MV1
Janke, LJ1

Other Studies

1 other study available for fenofibrate and Osteonecrosis

ArticleYear
Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice.
    Haematologica, 2021, 08-01, Volume: 106, Issue:8

    Topics: Animals; Dexamethasone; Fenofibrate; Fusion Proteins, bcr-abl; Mice; Osteonecrosis; Precursor Cell L

2021